WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2009057119) GLYCEMIC CONTROL FOR REDUCTION OF CARDIOVASCULAR DISEASE RISK IN DIABETIC PATIENTS EXPRESSING HAPTOGLOBIN 2-2
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2009/057119    International Application No.:    PCT/IL2008/001434
Publication Date: 07.05.2009 International Filing Date: 02.11.2008
IPC:
C12Q 1/68 (2006.01), G01N 33/53 (2006.01)
Applicants: RAPPAPORT FAMILY INSTITUTE FOR RESEARCH IN THE MEDICAL SCIENCES [IL/IL]; Efron Street, Bat Galim P.O. Box 9697 Haifa 31096 (IL) (For All Designated States Except US).
LEVY, Andrew [IL/IL]; (IL) (For US Only)
Inventors: LEVY, Andrew; (IL)
Agent: PEARL COHEN ZEDEK LATZER; Shenkar 5 PO Box 12704 46733 Herzlia (IL)
Priority Data:
60/996,105 01.11.2007 US
Title (EN) GLYCEMIC CONTROL FOR REDUCTION OF CARDIOVASCULAR DISEASE RISK IN DIABETIC PATIENTS EXPRESSING HAPTOGLOBIN 2-2
(FR) CONTRÔLE DE LA GLYCÉMIE EN VUE DE RÉDUIRE LE RISQUE DE MALADIES CARDIO-VASCULAIRES CHEZ LES PATIENTS DIABÉTIQUES EXPRIMANT L'HAPTOGLOBINE 2-2
Abstract: front page image
(EN)This invention relates to methods of reducing risk of developing cardiovascular complications in diabetic patients. Specifically, the invention relates to the use of haptoglobin genotyping for determining the importance of maintaining tight glycemic control in diabetic subjects expressing Hp 2-2 allele.
(FR)La présente invention concerne des procédés de réduction du risque de développement de complications cardiovasculaires chez les patients diabétiques. Spécifiquement, l'invention concerne l'utilisation du génotypage de l'haptoglobine pour déterminer l'importance du maintien d'un contrôle strict de la glycémie chez des sujets diabétiques exprimant l'allèle Hp 2-2.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)